Covered recipient · General Payments record
AMY NICOLE FERRARO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2025
$676.87
- Reported across 13 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $676.87 | 13 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | $146.23 | 1 |
| Pulmonx Corporation | $110.45 | 1 |
| Lundbeck LLC | $96.94 | 1 |
| PROCEPT BioRobotics Corporation | $75.83 | 1 |
| Endo USA, Inc. | $61.17 | 2 |
| TOLMAR, INC. | $57.56 | 2 |
| UROGEN PHARMA, INC. | $38.24 | 1 |
| Teleflex LLC | $26.29 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.20 | 1 |
| Teva Pharmaceuticals USA, Inc. | $21.43 | 1 |
| Sumitomo Pharma America, Inc. | $20.53 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $676.87 | 13 |
Payment records · PY2025 (13)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $146.23 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212796442 | CMS |
| Endo USA, Inc. | $26.00 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201223501 | CMS |
| Endo USA, Inc. | $35.17 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201223503 | CMS |
| Lundbeck LLC | $96.94 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251898095 | CMS |
| Novartis Pharmaceuticals Corporation | $22.20 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200274990 | CMS |
| Procept Biorobotics Corporation | $75.83 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249760239 | CMS |
| Pulmonx Corporation | $110.45 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1199552124 | CMS |
| Sumitomo Pharma America, Inc. | $20.53 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176761009 | CMS |
| Teleflex LLC | $26.29 | 10/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242463539 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.43 | 09/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247444218 | CMS |
| TOLMAR, INC. | $29.86 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237024234 | CMS |
| TOLMAR, INC. | $27.70 | 11/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237024320 | CMS |
| UROGEN PHARMA, INC. | $38.24 | 12/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244830260 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.